C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2011
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251169 Arylethynyl derivatives
10/13/2011	US20110251168 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/13/2011	CA2795513A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/13/2011	CA2794801A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
10/12/2011	EP2374804A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/12/2011	EP2373648A1 Substituted 1-(thiazolyl)- and 1-(isothiazolyl)pyrazole-4-yl-acetic acids, method for the production thereof and the use thereof as herbicides and plant growth regulators
10/12/2011	EP2373647A1 Pyridazinone derivatives
10/12/2011	EP2373646A1 Phthalazinone and related analogs as sirtuin modulators
10/12/2011	EP2373644A1 Pyridazinone derivatives
10/12/2011	EP2373639A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
10/12/2011	EP2373635A1 Benzothiazolone derivative
10/12/2011	EP2373634A1 Morpholinone compounds as factor ixa inhibitors
10/12/2011	EP2373629A1 Compounds for treating cancer
10/12/2011	EP2373172A1 Inhibitors of hcv ns5a
10/12/2011	EP2373163A1 Heterocyclic compounds and methods of use
10/12/2011	EP2077846B1 Benzoxazepine compounds, their preparation and use
10/12/2011	EP1919906B1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
10/12/2011	EP1761522B1 Compounds and methods for treating dyslipidemia
10/12/2011	EP1537180B1 Process for preparing azo compound
10/12/2011	CN1849318B Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/12/2011	CN1830977B Novel process for preparation of 2-aminothiazolecarboxamide derivatives
10/12/2011	CN102216296A Heterocyclyl-substituted thiazoles as plant protection agents
10/12/2011	CN102216291A Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
10/12/2011	CN102216285A Tetrasubstituted pyridazine hedgehog pathway antagonists
10/12/2011	CN102216277A Novel compounds as cannabinoid receptor ligands
10/12/2011	CN102212030A Substituted tetrahydrocarbazole antifungal compounds and preparation method thereof
10/12/2011	CN101389613B Macrocyclic factor viia inhibitors useful as anticoagulants
10/12/2011	CN101296909B Pyrazine derivatives and use as pI3K inhibitors
10/11/2011	US8034959 Methods of treating cancer with an antibody-drug conjugate
10/11/2011	US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
10/11/2011	US8034954 Calcium channel antagonists
10/11/2011	US8034949 Pyrrolidine compound and a process for preparing the same
10/11/2011	US8034832 Gyrase inhibitors and uses thereof
10/11/2011	US8034818 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
10/11/2011	US8034815 Imidazol-1-yl-(4-pyridin-2-yl-piperazin-1-yl)-methanethione; Critical Outcome Technologies' Iead compound (COTI); kinase inhibitor; anticarcinogenic agent; especially small cell lung cancer; cervical, ovarian, skin, prostate, breast, colorectal, head, neck, or kidney cancer, sarcoma, leukemia
10/11/2011	US8034811 Hydroxamic acid esters and pharmaceutical use thereof
10/11/2011	CA2682494C Hexahydro-1h-4,7-methanoisoindole-1,3-dione compounds for treating psychiatric disorders
10/11/2011	CA2551909C Substituted azole derivatives, compositions, and methods of use
10/11/2011	CA2520852C 7-([1,4]dioxan-2-yl)-benzothiazole derivative as adenosine receptor ligands
10/11/2011	CA2514191C Compound inhibiting dipeptidyl peptidase iv
10/11/2011	CA2504907C Indoles useful in the treatment of androgen-receptor related diseases
10/06/2011	WO2011123674A1 Compounds for treating neurodegenerative diseases
10/06/2011	WO2011122815A2 Novel quinoxaline derivatives
10/06/2011	WO2011121418A1 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
10/06/2011	WO2011080255A3 Fungicidal hydroximoyl - tetrazole derivatives
10/06/2011	WO2011080254A3 Fungicide hydroximoyl-heterocycles derivatives
10/06/2011	WO2011045415A3 Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
10/06/2011	US20110245493 Delivery of drug amines through an inhalation route
10/06/2011	US20110245295 Bioactive pre-tubulysins and use thereof
10/06/2011	US20110245267 Piperidine and piperazine derivatives and methods of use thereof
10/06/2011	US20110245243 Compounds and compositions as cathepsin s inhibitors
10/06/2011	US20110245239 Organic compounds
10/06/2011	US20110245226 Piperidinyl derivatives as modulators of chemokine receptor activity
10/06/2011	US20110245223 Heterocyclic compounds
10/06/2011	US20110245205 Aminopyrimidines as syk inhibitors
10/06/2011	US20110243850 Probe for a biological specimen and labelling method and screening method using the probe
10/06/2011	US20110243846 Benzothiazole amides for detection of amyloid beta
10/06/2011	CA2795009A1 Aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
10/05/2011	EP2371826A1 Novel fused ring compound and use thereof
10/05/2011	EP2371822A1 Heterobicyclic carboxamides as inhibitors for kinases
10/05/2011	EP2371366A1 Heterocyclo inhibitors of potassium channel function
10/05/2011	EP2370433A2 A method for the preparation of tizanidine hydrochloride
10/05/2011	EP2370432A2 A process for preparing quetiapine fumarate
10/05/2011	EP2370427A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and uses thereof
10/05/2011	EP2370426A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and uses thereof
10/05/2011	EP2370425A2 Fused imidazole derivatives as trpv3 antagonist
10/05/2011	EP2370407A1 Carbazole and carboline kinase inhibitors
10/05/2011	EP2370406A1 High penetration compositions and their applications
10/05/2011	EP2370111A1 Probe for a biological specimen and labelling method and screening method using the probe
10/05/2011	EP2370110A1 Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method
10/05/2011	EP1966151B1 Polycyclic indazole derivatives that are erk inhibitors
10/05/2011	EP1960370B1 Pyridiazinone derivatives for tumour treatment
10/05/2011	EP1958948B1 Pyridazine compound and use thereof
10/05/2011	EP1888558B1 Bicyclic derivatives as modulators of ion channels
10/05/2011	EP1575940B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
10/05/2011	EP1567490B1 Anti-sickling agents
10/05/2011	EP1454903B9 Thiadiazoline derivatives for treating cancer
10/05/2011	CN1896069B Substituted-thiazole-4-ketone, its preparation and use
10/05/2011	CN102209718A Carbamate compound or salt thereof
10/05/2011	CN102209717A Compounds for the treatment of hepatitis c
10/05/2011	CN102209716A Novel compounds as cannabinoid receptor ligands
10/05/2011	CN102209715A 4-halo-3 -amino- l, 2 -benzisothiazole compounds as pesticides
10/05/2011	CN102209714A Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
10/05/2011	CN102209537A Heterocyclic gamma secretase modulators
10/05/2011	CN102206214A Benzopyrone derivative and application thereof
10/05/2011	CN102206207A 4-aryl pyrimidine or 4-heterocyclic aryl pyrimidine compound luminescent material and preparation method thereof
10/05/2011	CN101031558B HIV inhibiting 5-heterocyclyl pyrimidines
10/04/2011	US8032873 Computer program code size partitioning system for multiple memory multi-processing systems
10/04/2011	US8030497 Benzimidazole derivatives
10/04/2011	US8030339 Imidazole derivatives for the treatment of anxiety and related diseases
10/04/2011	US8030331 Allosteric modulators of metabotropic glutamate receptors
10/04/2011	US8030309 Viral polymerase inhibitors
10/04/2011	US8030303 Salt of morpholine compound
10/04/2011	CA2507501C 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/04/2011	CA2438520C Phthalazinone-piperidino-derivatives as pde4 inhibitors
10/04/2011	CA2426031C 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
10/03/2011	WO2011027806A1 Therapeutic agent for anxiety disorders
10/03/2011	CA2772922A1 Therapeutic agent for anxiety disorders
10/03/2011	CA2772920A1 Therapeutic agent for mood disorders

1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 628